
Journal of Organometallic Chemistry p. 63 - 82 (1993)
Update date:2022-08-03
Topics:
Walter, Olaf
Klein, Thomas
Huttner, Gottfried
Zsolnai, Laszlo
The tripod ligand H3CC(CH2PPh2)3, 1, reacts with lithium metal to produce H3CC(CH2PPhLi)3, 2, in good yields.Compound 2 crystallizes in the form of 2*4THF*MeN(CH2CH2NMe2)2.The crystal structure of this adduct shows bridging as well as terminal phosphorous-coordination of lithium.Compound 2 reacts with electrophiles RX to give H3CC(CH2P(Ph)(R))3, 3 (R = H, Me, Et, iPr, CH2Ph, 3a-e).The transformation 1 <*> 2 <*> 3 can be performed in a one-pot reaction.While the chiral compounds 3 may be characterized as such, their reaction with (CH3CN)3Mo(CO)3 yields theeasy-to-characterize coordination compounds H3CC(CH3P(Ph)(R))3Mo(CO)3, 5.NMR analysis of 3 and 5 shows that from the two diastereomeric forms of 3 (the enantiomeric pair SSR/RRS and the pair SSS/RRR) only the SSR/RRS-diastereomer is formed with R = CH2Ph (3e, 5e).In the other cases (R = H, Me, Et, iPr) a statistical 3:1 mixture of the two diastereomers is formed.These findings are further corroborated by X-ray analyses of H3CC(CH2P(Ph)(Et))3Mo(CO)3, 5c, and H3CC(CH2P(Ph)(CH2Ph))3Mo(CO)3, 5e.The remarkable facts reported in this paper are the ease with which the chiral tripod ligands H3CC(CH2P(Ph)(R))3, 3, are prepared, and the evidence that their formation may well involve diastereoselective control.
View MoreZhejiang Sucon Silicone Co.,Ltd
Contact:+86-575-88046692
Address:Qisheng Rd., Paojiang Industrial Zone, Shaoxing, Zhejiang, China.
Chongqing Yawei Fine Chemical Co.,Ltd
Contact:0086-23-62849407
Address:Ziyou village, Nanquan town, Banan district, Chongqing China
Contact:86-21 60347964
Address:No.1304, West Meilong Road, Minhang District, Shanghai, China
Haitong Chemical Industrial Co.,Ltd.
website:https://www.haitonglongwin.com/
Contact:+86-022-66221018
Address:18-701, No.99, The 4th Street, TEDA,
ZHEJIANG CHEMICAL INDUSTRY INSTITUTE TECHNOLOGY CO.,LTD(expird)
Contact:86-575-82730298
Address:shangyu
Doi:10.1016/S0040-4039(01)01825-1
(2001)Doi:10.1039/c3ra46270f
(2014)Doi:10.1080/00397910903340637
(2010)Doi:10.1016/0223-5234(93)90114-T
(1993)Doi:10.1055/s-1993-26037
(1993)Doi:10.7164/antibiotics.46.1919
(1993)